Not Yet RecruitingNot Applicable

Impact of Glycemic Control on Penile Duplex Results

100 participantsStarted 2025-01

Plain-language summary

The study aimed at evaluating the impact of glycemic control on the erectile function , penile Doppler, and cavernosal blood NO and glutathione levels among a group of diabetic patients with erectile dysfunction.

Who can participate

Age range30 Years – 55 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Married Male patients diagnosed with erectile dysfunction. * Age from 30 to 55 years. * Documented history of DM. * Regular sexual life with cooperative wife. Exclusion Criteria: * Patients with congenital anomalies like hypospadius and curvature. * History of pelvic or spine surgery. * Single patient. . Thyroid disorders. * Other sexual disorders. * Primary ED. * History of Peyronie's disease or priapism.

What they're measuring

Penile doppler ultrasound

Timeframe: Baseline

Cavernosal blood nitric oxide

Timeframe: Baseline

Cavernosal blood glutathione level

Timeframe: Baseline

Trial details

NCT IDNCT06220968

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-01

Contact for this trial

Mahmoud Ab Khalaf

01220570189 MahmoudFakir152997@gmail.com

View on ClinicalTrials.gov More Erectile Dysfunction With Diabetes Mellitus trials